Precision Neuroscience is a brain-computer interface (BCI) company developing high-resolution, minimally invasive neural implants to treat patients with neurological conditions. Founded in 2022 by members of the BrainGate research consortium, the company focuses on restoring independence for people with paralysis, stroke, and neurodegenerative diseases["@precision"].
...
Overview
Mermaid diagram (expand to render)
Precision Neuroscience is a brain-computer interface (BCI) company developing high-resolution, minimally invasive neural implants to treat patients with neurological conditions. Founded in 2022 by members of the BrainGate research consortium, the company focuses on restoring independence for people with paralysis, stroke, and neurodegenerative diseases["@precision"].
The company's founding team brings extensive experience from the BrainGate consortium, which has conducted pioneering research in neural interfaces for over two decades. This expertise provides a strong foundation for developing next-generation BCI technology that balances signal quality with surgical safety["@precision"].
Technology
The Precision Micro-Electrocorticography (pECoG) Array
Precision Neuroscience's core technology is a thin-film, high-density micro-ECoG array that sits on the surface of the brain beneath the dura mater. This approach represents a significant advancement over traditional invasive BCI methods[@braingate]:
Key features include[@braingate][@highresolution]:
High Spatial Resolution: Much higher than standard ECoG or EEG, enabling finer neural decoding
Minimally Invasive: Does not require brain penetration, dramatically reducing surgical risk
Broad Cortical Coverage: Can cover large brain areas with uniform signal quality
Chronic Implantation: Designed for long-term use with minimal tissue response
Thin-Film Construction: Ultra-flexible substrate conforms to brain surface anatomy
Technical Specifications
The pECoG array incorporates advanced engineering[@highresolution]:
Unlike fully invasive approaches like [Neuralink](/technologies/neuralink) or [Blackrock Neurotech](/technologies/blackrock-neurotech) that penetrate brain tissue, Precision Neuroscience's pECoG approach offers unique advantages[@microecog]:
Surface Placement: Sits on the brain surface, avoiding damage to neural tissue
Higher Signal Quality: Provides signals with significantly higher spatial resolution than scalp EEG
Middle Ground: Offers optimal balance between safety and signal quality
Reduced Immune Response: Less tissue damage leads to more stable long-term signals
Clinical Applications
Motor Restoration
The primary application is enabling motor restoration for patients with[@precision]:
Spinal Cord Injury: Restoring voluntary movement through neural decoding
Stroke: Supporting rehabilitation and potential motor recovery
Amyotrophic Lateral Sclerosis (ALS): Maintaining communication and control
Multiple Sclerosis: Preserving motor function in progressive disease
Neurodegenerative Disease Applications
For neurodegenerative diseases, Precision Neuroscience's technology offers significant potential[@precision][@braingate]:
Neural Monitoring: High-resolution recording for studying disease progression in Alzheimer's and Parkinson's
Brain-Computer Interface Control: Enable external device control through decoded neural signals
Rehabilitation Support: Motor rehabilitation through closed-loop feedback
Biomarker Discovery: Detailed neural signatures for disease progression tracking
Alzheimer's Disease Applications
The high-resolution recording capabilities enable novel Alzheimer's research[@braingate]:
Hippocampal Cortical Dynamics: Recording from surface electrodes over temporal regions
Memory Circuit Mapping: Identifying functional changes in memory-related networks
Treatment Response Monitoring: Objective neural markers for therapeutic efficacy
Early Detection: High-resolution signals may reveal preclinical changes
Parkinson's Disease Applications
For Parkinson's disease, the technology offers[@braingate]:
Motor Cortex Recording: Understanding cortical involvement in parkinsonian syndromes
Deep Brain Stimulation Integration: Potential for closed-loop DBS systems
Levodopa Response Monitoring: Objective measures of medication effects
Dyskinesia Detection: Early identification of treatment complications
Clinical Status
Precision Neuroscience has achieved significant milestones[@precision]:
Successful Early Human Implantations: Proof-of-concept demonstrations
Regulatory Clearance: Received FDA approval for clinical studies
High-Quality Signal Recording: Demonstrated excellent neural signal quality in humans
Safety Profile: No serious adverse events in initial trials
Company Background
The company was founded by alumni of the BrainGate research consortium, which has a long history of neural interface research[@precision]. This expertise provides:
Proven Track Record: Decades of experience in neural decoding
Clinical Trial Experience: Established protocols for BCI trials
Academic Partnerships: Collaborations with leading research institutions
Regulatory Knowledge: Understanding of FDA approval processes
Competitive Landscape
Precision Neuroscience occupies a unique position in the BCI landscape[@microecog]: